Dr. Anant Madabhushi is the Director of the Center for Computational Imaging and Personalized Diagnostics (CCIPD) and a Professor in the Departments of Biomedical Engineering, Pathology, Radiology, Radiation Oncology, Urology, General Medical Sciences, and Electrical Engineering and Computer Science at Case Western Reserve University.
Dr. Madabhushi received his Bachelors Degree in Biomedical Engineering from Mumbai University, India in 1998 and his Masters in Biomedical Engineering from the University of Texas, Austin in 2000. In 2004 he obtained his PhD in Bioengineering from the University of Pennsylvania. He joined the Department of Biomedical Engineering, Rutgers University as an Assistant Professor in 2005. He was promoted to Associate Professor with Tenure in 2010. In 2012 he accepted the position of Associate Professor at Case Western Reserve University, Department of Biomedical Engineering andis currently directing a center on computational imaging and personalized diagnostics. He was promoted to full professor in 2014.
Dr. Madabhushi has authored over 240 peer-reviewed publications in leading international journals and conferences. He has 9 issued patents with over 20 patents pending in the areas of medical image analysis, computer-aided diagnosis, and computer vision. He is an Associate Editor for IEEE Transactions on Biomedical Engineering, IEEE Transactions on Biomedical Engineering Letters, BMC Cancer, BMC Medical Imaging, Journal of Medical Imaging and Medical Image Analysis (MedIA). He is also on the Editorial Board of the Journal Analytical and Cellular Pathology. He has been the recipient of a number of awards for both research as well as teaching, including the Department of Defense New Investigator Award in Lung Cancer (2014), the Coulter Phase 1 and Phase 2 Early Career award (2006, 2008), and the Excellence in Teaching Award (2007-2009), along with a number of technology commercialization awards. He is also a Wallace H. Coulter Fellow, a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), and a Senior IEEE member. In 2015 he was named by Crains Cleveland Business Magazine as one of Forty under 40 making positive impact to business in North East Ohio. His research work has received grant funding from the National Cancer Institute (NIH), National Science Foundation, the Department of Defense, private foundations, and from Industry.
He is also the co-founder of Ibris Inc. a startup company focused on developing image based assays for breast cancer prognosis. He is also the conference chair for the new Digital Pathology Conference to be held annually in conjunction with the SPIE Medical Imaging Symposium.